BioFocus DPI has extended its drug discovery agreement with Eli Lilly and Company until end 2009.
Researchers have developed a new method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer.
Researchers at Children’s Hospital Boston show that a small protein called lipocalin 2 triggers the EMT in human breast cancer, and that the same protein, when measured in tissues and urine, can predict a cancer's invasiveness.
The Pittcon 2009 Exposition, which takes place March 8-13, McCormick Place South, Chicago, Illinois will showcase 1,000 exhibitors that manufacture, distribute, and market products for laboratory science.
Hybrigenics announced it has signed a substantial contract as part of a large-scale European Union research project called MASTERSWITCH.
Ambrx Inc. and Merck Serono announced a collaboration to develop and commercialize Ambrx’s ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Vaccine manufacturers have substantially increased their capacity to produce pandemic influenza vaccines during the past two years, according to a new study by Oliver Wyman.
Pfizer Inc. said it is ending development of two medicines that had been in final human testing in order to shift funding to other experimental drugs with more potential.
MAP Pharmaceuticals, Inc. announced the results of its initial Phase 3 clinical trial of Unit Dose Budesonide (UDB) for the potential treatment of children with asthma.
MDS Analytical Technologies announced that its Arcturus Laser Capture Microdissection (LCM) instruments were used by researchers at the University of Cincinnati in their discovery of genetic variations that may prove to be key predictors of risk for colon cancer.
Federal health officials warned doctors that a drug used in epilepsy patients can cause chemical imbalances in the blood, leading to heart problems and other serious complications.
Taking B vitamins can prevent a common type of vision loss in older women, according to a study.
Scientists have harnessed a new drug discovery tool to identify a new player in the body’s insulin secretion process.
Research has found that steroid tablets do not reduce the symptoms of virus-induced wheezing in pre-school children.